Clinical trial
Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616…
NCT00474617 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00474617 |
|---|---|
| Title | Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029) |
| Official title | A Multicenter, Parallel Group, Comparative, Phase IIIa Trial to Compare the Efficacy, Safety, and Pharmacokinetics of Org 25969 in Elderly Subjects With Adult Subjects |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anesthesia, General |
| Intervention type | Drug |
| Interventions | Sugammadex, Rocurium |
| Enrollment | 162 |
| Start date | Dec 29, 2005 |
| Primary completion | Oct 20, 2006 |
| Completion | Oct 20, 2006 |
| First posted | May 17, 2007 |
| Last update posted | Apr 2, 2019 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: